ARCHIVES

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

BRCA 1 Mutation Finding Draws Attention To Potential Perils Of Genetic Testing

October 6, 1995

Nurses Pass Resolution To Support Research on Ethnic Patient Issues

May 29, 1992

Chabner : Opportunity To Set Own Agenda Reason For Leaving

October 28, 1994

FDA Approves New Toxicology Protocol; Drug Program Under Fire; DCT Board Approves Cutbacks, Contract Concepts

October 9, 1981

Novel Four Drug Combination Safe For Lung Cancer Therapy

November 28, 2008

Control AC Hear Report On High Risk conference, Messer Survey

September 6, 1974